Tuberculosis among pregnant women in Ethiopia independently correlated with HIV infection and increasing age, which suggests that young women in the country are continuously exposed to, and infected with, contagious TB, according to findings in Clinical Infectious Diseases.

The deadliest infectious disease in the world is still TB. Former patient and activist Ksenia Shchenina from Russia tells the documentary channel RT Doc the harrowing story of her experience with the illness, and why it's not the germ, but the terrain it finds, that is the real problem.

-- Deltyba® (delamanid) — an essential medicine according to the World Health Organization [1] — is now available in Russia for difficult-to-treat MDR-TB patients.
-- Deltyba® (delamanid), developed by Otsuka Pharmaceutical Co., Ltd. based in Japan, is commercialized in Russia by the R-Pharm group of companies.

Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT), the Center for Global Infectious Disease Research – Seattle in the United States, and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to serve multiple functions in the fight against TB.

The Stop TB partnership predicts an additional 1.4 million people will die from TB by 2025 thanks to the COVID-19 response.

An op-ed published in The Wire Science discusses how ‘covidisation’ of the health system in India has impacted the other 'killers', especially TB.

May 20, 2020 -- New research by scientists from the United Kingdom and Africa suggests a long-standing practice of using antibiotics to test whether an individual may have tuberculosis (TB) is an unreliable method for diagnosing the disease.

Rates of tuberculosis recurrence increased by almost ninefold between episode 2 and 5 regardless of HIV status, according to a study assessing recurrent tuberculosis in Cape Town, South Africa, over a 13-year period.

The 73rd World Health Assembly adopts a resolution to bring the world together to fight the COVID-19 pandemic.

Aidspan: Global Fund Observer